CAR-mediated repression of Cdkn1a(p21) is accompanied by the Akt activation

It was shown that CAR participates in the regulation of many cell processes. Thus, the activation of CAR causes a proliferating effect in the liver, which provides grounds to consider CAR as a therapeutic target when having a partial resection of this organ. Even though a lot of work has been done o...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 504; no. 2; pp. 361 - 366
Main Authors Yarushkin, Andrei A., Mazin, Mark E., Yunusova, Anastasia Y., Korchagina, Kseniya V., Pustylnyak, Yuliya A., Prokopyeva, Elena A., Pustylnyak, Vladimir O.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 02.10.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:It was shown that CAR participates in the regulation of many cell processes. Thus, the activation of CAR causes a proliferating effect in the liver, which provides grounds to consider CAR as a therapeutic target when having a partial resection of this organ. Even though a lot of work has been done on the function of CAR in regulating hepatocyte proliferation, very little has been done on its complex mediating mechanism. This study, therefore, showed that the liver growth resulting from CAR activation leads to the decline in the level of PTEN protein and subsequent Akt activation in mouse liver. The increase of Akt activation produced by CAR agonist was accompanied by a decrease in the level of Foxo1, which was correlated with decreased expression of Foxo1 target genes, including Cdkn1a(p21). Moreover, the study also demonstrated that there exists a negative regulatory impact of CAR on the relationship between Foxo1 and targeted Cdkn1a(p21) promoter. Therefore, the study results revealed an essential function of CAR-Akt-Foxo1 signalling pathway in controlling hepatocyte proliferation by repressing the cell cycle regulator Cdkn1a (p21). •CAR-mediated liver growth is accompanied by the decrease in PTEN.•CAR-mediated liver growth is accompanied by the Akt activation.•CAR-mediated Akt activation is accompanied by the decrease in Foxo1.•CAR activation decreased the level of p21.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2018.06.032